To use or not to use: The dilemma of NSAIDs and craniotomy

European Journal of Anaesthesiology

Volumn 26, Issue 8, 2009, Pages 625-626

  Rao, Ganne S Umamaheswara ^a   Gelb, Adrian W ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; LORNOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; PROSTAGLANDIN SYNTHASE;

CRANIOTOMY; DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; BLOOD CLOTTING; DRUG EFFECT; METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD COAGULATION; CRANIOTOMY; CYCLOOXYGENASE 2 INHIBITORS; HUMANS; PAIN, POSTOPERATIVE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 70249116809     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832a21ad     Document Type: Editorial

References (22)

1. Talke PO, Gelb AW. Post craniotomy pain remains a real headache!. Eur J Anaesthesiol 2005; 22: 325-327.
2. Gottschalk A, Berkow LC, Stevens RD, et al. Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg 2007; 106: 210-216.
3. Bala I, Gupta B, Bhardwaj N, et al. Effect of scalp block on postoperative pain relief in craniotomy patients. Anaesth Intensive Care 2006; 34: 224-227.
4. Rahimi SY, Vender JR, Macomson SD, et al. Postoperative pain management after craniotomy: evaluation and cost analysis. Neurosurgery 2006; 59: 852-857.
5. Dolmatova EV, Imaev AA, Lubnin AY. 'Scheduled' dosing of lornoxicam provides analgesia superior to that provided by 'on request' dosing following craniotomy. Eur J Anaesthesiol 2009; 26: 633-637.
6. Karaman Y, Kebapci E, Gurkan A. The preemptive analgesic effect of lornoxicam in patients undergoing major abdominal surgery: a randomised controlled study. Int J Surg 2008; 6: 193-196.
7. Moore AR, Derry S, McQuay HJ. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. BMC Muscuioskeiet Disord 2007; 8: 73.
8. Bombardier C, Laine L, Reicin A, et al., VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-1528.
9. Bresalier RS, Sandler RS, Quan H, et al., Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092-1102.
10. Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circuiation 2006; 113: 2906-2913.
11. Ott E, Nussmeier NA, Duke PC, et al. Efficacy and safety of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003; 125: 1481-1492.
12. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005; 352: 1081-1091.
13. Nussmeier NA, Whelton AA, Brown MT, et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesioiogy2006; 104: 518-526.
14. Palmer JD, Sparrow OC, lanotti F. Postoperative haematoma: a five-year survey and identification of avoidable risk factors. Neurosurgery 1994; 35: 1061 -1065.
15. Robinson CM, Christie J, Malcom-Smith N. Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthropiasty 1993; 8: 607-610.
16. Leese PT, Hubbard RC, Karim A, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Ciin Pharmacoi 2000; 40: 124-132.
17. Meunier A, Lisander B, Good L. Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial. Acta Orthopaedica 2007; 78: 661 -667.
18. Hegi TR, Bombeli T, Seifert B, et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 2004; 92: 523-531.
19. Ejaz P, Bhojani K, Joshi VR. NSAIDs and kidney. J Assoc Physicians India 2004; 52: 632-640.
20. Zhang J, Ding EL, Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 2006; 296: 1619 -1632.
21. Candelario-Jalil E, Gonzalez-Falcon A, Garcia-Cabrera M, et al. Assessment of the relative contribution of COX-1 and COX-2 isoforms to schema-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 2003; 86: 545-555.
22. Sasaki T, Kitagawa K, Yamagata K, et al. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2- deficient mice. J Cereb Biood Fiow Metab 2004; 24: 107-113.